ROIV
NASDAQ · Biotechnology
Roivant Sciences Ltd
$28.56
+0.28 (+0.99%)
Performance
1D
—
1W
—
1M
—
3M
+4.42%
6M
+33.96%
1Y
+159.87%
YTD
+30.23%
Open$28.36
Previous Close$28.28
Day High$28.90
Day Low$28.17
52W High$30.33
52W Low$10.58
Volume—
Avg Volume4.60M
Market Cap20.24B
P/E Ratio—
EPS$-1.17
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.00
Above
SMA 200
$16.34
Above
RSI (14)
76.4
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+181.6% upside
Current
$28.56
$28.56
Target
$80.43
$80.43
$62.72
$80.43 avg
$106.86
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.42M | 35.21M | 2.76B |
| Net Income | -168,029,075 | -187,393,020 | -140,854,131 |
| Profit Margin | -592.0% | -562.4% | -5.1% |
| EBITDA | -958,495,676 | -1,128,340,634 | -182,068,335 |
| Free Cash Flow | — | — | -125,369,781 |
| Rev Growth | -19.3% | -19.3% | -1.7% |
| Debt/Equity | — | — | 0.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |